Our turn-key, manufacturing, continuous flow facility innovations are highly automated, controlled and inexpensive to build and operate. We have worked closely with the EPA to ensure that our facilities have the lowest environmental impact and smallest manufacturing foot print size possible. These features allow us to drive down drug costs and create a distributive, global, world-wide network of modular manufacturing facilities enabling Medicines-for-Demand.
What Our Customers Think:
ChemWerth has partnered with BPP to facilitate their innovative API discovery, development and manufacturing processes because we believe BPP's solution will result in better, quicker and higher quality solutions to supply global medicine demand.